208.12USD-4.62%Mkt Cap: 11.43B $P/E: —Today
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio …
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap11.43B $
Enterprise Value10.80B $
Revenue (TTM)776.57M $
Gross Profit591.02M $
Net Income (TTM)-183.17M $
Revenue/Share15.25 USD
Last Price208.12 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS05464T1043
Valuation
P/E (Trailing)—
P/E (Forward)41.33
PEG—
EV/EBITDA-62.47
EV/Revenue13.91
P/S14.03
P/B130.59
EPS (TTM)-3.58
EPS (Forward)5.03
52W Range
108.0466% of range260.19
52W High260.19 USD
52W Low108.04 USD
Profitability
Gross Margin92.56%
Oper. Margin-23.42%
EBITDA Margin-22.27%
Profit Margin-28.69%
ROE-207.46%
ROA-26.55%
Growth
Revenue Growth45.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-93.41M $
CapEx (TTM)480.00K $
FCF Margin-0.59%
FCF Yield-0.04%
Net Debt-95.16M $
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity2.47
Current Ratio1.43
Quick Ratio1.30
Book Value/Sh1.593 USD
Cash/Share6.106 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)285.42 USD
Upside (mean)+37.1%
Target Range246.00 USD – 380.00 USD
$246.00+37.1% to mean$380.00
# Analysts21
Ownership
Shares Out.52.38M
Float44.46M
Insiders15.08%
Institutions74.57%
Short Interest
Short Ratio4.5d
Short % Float10.11%
Short % Out.6.52%
Shares Short3.41M
Short (prev mo.)2.63M
Technical
SMA 50233.18 (-10.7%)
SMA 200191.07 (+8.9%)
Beta0.73
S&P 52W Chg18.16%
Avg Vol (30d)697.95K
Avg Vol (10d)789.04K
Technical Indicators
RSI (14)45.0
MACD-5.3101
MACD Signal-5.5585
MACD Hist.+0.2484
BB Upper245.19 USD
BB Middle222.34 USD
BB Lower199.49 USD
BB Width20.55%
ATR (14)8.458 USD
Vol Ratio (20d)0.61x